We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of Perioperative Protease Inhibitor on Inflammatory Cytokines and Acute-Phase Proteins in Patients with Hepatic Resection.
- Authors
Ambiru, S.; Miyazaki, M.; Sasada, K.; Ito, H.; Kimura, F.; Nakagawa, K.; Shimizu, H.; Ando, K.; Nakajima, N.
- Abstract
Aim: The objective of this study was to examine the effects of perioperative administration of ulinastatin, or urinary trypsin inhibitor (UTI), on inflammatory cytokines and acute-phase proteins induced by inflammatory cytokines in patients who had undergone hepatic resection. Method: Twenty patients admitted to the hospital for hepatic resection were equally randomized to one of two groups: the UTI group, those who were administered perioperative UTI, and the control group. Results: The UTI group had no adverse effects from using UTI. Production of serum interleukin-6 (IL-6) tended to be attenuated in the UTI group when compared with the control group. Moreover, the UTI group had significantly decreased positive acute-phase C-reactive protein (p < 0.05) and significantly increased negative acute-phase protein prealbumin and retinol-binding protein (p < 0.05). Serum IL-6 levels significantly correlated with serum C-reactive protein levels on postoperative day 1 (r = 0.70, p < 0.01). Conclusion: These results suggest that perioperative administration of UTI might deserve further assessment for use in modulating acute-phase responses without adverse effects in patients who have undergone hepatic resection. Copyright © 2000 S. Karger AG, Basel
- Publication
Digestive Surgery, 2000, Vol 17, Issue 4, p337
- ISSN
0253-4886
- Publication type
Article
- DOI
10.1159/000018875